HIGHLIGHTS
- who: Guilan Shi and collaborators from the Department of Medical Engineering, University of South Florida, Tampa, FL, USA have published the paper: Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
- what: This approach has been demonstrated to be effective against a large number of cancer types, including melanoma, non-small-cell lung cancer, and renal cancer . The authors show that MHC-I was upregulated in B16F10 tumor-bearing mice treated with vector GET and pIL-12 GET. Dependent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.